Recent

% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • frogsleapmerlot frogsleapmerlot Oct 19, 2010 10:42 AM Flag

    VMAT Inhibitor moving into P2 trials

    The fallen Angle status is gone

    The street is starting to fall in ♥ with NBIX and that is very very good for supporting a higher stock price.

    When NBIX announces that P3 E has started for Endo and P2 for UF.

    We go to double digits,,

    Again this stock is going to get valued like Vertex has gotten valued on its HepC inhibitor. huge MKT OPP and no good treatment options.

    frogs

 
NBIX
40.66-2.71(-6.25%)2:23 PMEDT